The Fort Worth Press - Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)

USD -
AED 3.67315
AFN 64.000049
ALL 82.460012
AMD 376.319875
AOA 916.999881
ARS 1387.01782
AUD 1.417284
AWG 1.8
AZN 1.698872
BAM 1.671981
BBD 2.012823
BDT 122.815341
BHD 0.377522
BIF 2970.5
BMD 1
BND 1.273995
BOB 6.905365
BRL 5.099299
BSD 0.999316
BTN 92.260676
BWP 13.408103
BYN 2.916946
BYR 19600
BZD 2.009908
CAD 1.38394
CDF 2301.000244
CHF 0.790475
CLF 0.022811
CLP 897.589607
CNY 6.830101
CNH 6.82964
COP 3647.59
CRC 464.865789
CUC 1
CUP 26.5
CVE 94.850263
CZK 20.876297
DJF 177.71977
DKK 6.3992
DOP 60.649813
DZD 132.405958
EGP 53.243098
ERN 15
ETB 155.625025
EUR 0.85632
FJD 2.21345
FKP 0.755232
GBP 0.744985
GEL 2.685001
GGP 0.755232
GHS 11.015012
GIP 0.755232
GMD 72.999884
GNF 8780.000114
GTQ 7.645223
GYD 209.079369
HKD 7.832385
HNL 26.619914
HRK 6.454497
HTG 131.013289
HUF 321.89703
IDR 17004.45
ILS 3.08836
IMP 0.755232
INR 92.35715
IQD 1310
IRR 1315000.000248
ISK 123.159804
JEP 0.755232
JMD 157.315666
JOD 0.708974
JPY 158.396008
KES 129.4008
KGS 87.449889
KHR 4014.000047
KMF 424.495348
KPW 899.988897
KRW 1478.329964
KWD 0.30913
KYD 0.832781
KZT 477.797202
LAK 21962.503045
LBP 89550.000312
LKR 315.00748
LRD 184.201804
LSL 16.614988
LTL 2.95274
LVL 0.60489
LYD 6.344954
MAD 9.305012
MDL 17.208704
MGA 4137.497373
MKD 52.749143
MMK 2100.006416
MNT 3571.582477
MOP 8.062591
MRU 40.100639
MUR 46.770317
MVR 15.460342
MWK 1736.999694
MXN 17.41705
MYR 3.975971
MZN 63.95994
NAD 16.609452
NGN 1377.969888
NIO 36.730261
NOK 9.55728
NPR 147.619434
NZD 1.71469
OMR 0.384503
PAB 0.999308
PEN 3.40375
PGK 4.310014
PHP 59.562017
PKR 278.999834
PLN 3.635519
PYG 6482.581748
QAR 3.645993
RON 4.362498
RSD 100.488021
RUB 78.546657
RWF 1460.5
SAR 3.752479
SBD 8.04851
SCR 14.117697
SDG 601.000039
SEK 9.29082
SGD 1.27332
SLE 24.650107
SOS 571.499594
SRD 37.553992
STD 20697.981008
STN 21.44
SVC 8.744604
SYP 110.549356
SZL 16.614985
THB 32.016497
TJS 9.498763
TMT 3.5
TND 2.891983
TRY 44.5205
TTD 6.778082
TWD 31.728984
TZS 2587.523004
UAH 43.307786
UGX 3697.197396
UYU 40.598418
UZS 12230.000021
VES 474.416904
VND 26332.5
VUV 119.420937
WST 2.770913
XAF 560.735672
XAG 0.013279
XAU 0.000211
XCD 2.70255
XCG 1.8011
XDR 0.698977
XOF 608.999818
XPF 102.549639
YER 238.575002
ZAR 16.358585
ZMK 9001.174966
ZMW 19.112505
ZWL 321.999592
  • CMSC

    0.1500

    22.29

    +0.67%

  • BCC

    4.5200

    79.23

    +5.7%

  • RBGPF

    -13.5000

    69

    -19.57%

  • RYCEF

    -0.5000

    15.25

    -3.28%

  • JRI

    0.1600

    12.85

    +1.25%

  • CMSD

    0.2100

    22.5

    +0.93%

  • BCE

    0.2900

    24.12

    +1.2%

  • RELX

    0.5700

    33.93

    +1.68%

  • NGG

    2.4400

    89.96

    +2.71%

  • RIO

    3.7900

    98.45

    +3.85%

  • GSK

    1.5300

    57.37

    +2.67%

  • VOD

    0.4600

    15.77

    +2.92%

  • BTI

    1.1500

    59.95

    +1.92%

  • AZN

    3.4600

    204.27

    +1.69%

  • BP

    -1.3500

    45.89

    -2.94%

Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)
Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)

Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)

Beverly Hills spine surgeons complete three-level cervical disc replacement following recent FDA approval of motion-preserving technology

Text size:

BEVERLY HILLS, CA / ACCESS Newswire / April 8, 2026 / Todd H. Lanman, MD, and Joel S. Beckett, MD have performed the first post-approval case using the newly FDA-approved Synergy Disc®, marking an early clinical milestone for the motion-preserving cervical disc technology.

The procedure was performed on Monday at the Advanced Surgery Center of Beverly Hills five weeks after the U.S. Food and Drug Administration (FDA) granted Premarket Approval (PMA) for the Synergy Disc® for single-level cervical disc replacement from C3-C7.

The patient, a 47-year-old man, presented with progressive neck pain, arm pain, and weakness in the setting of spinal cord compression and severe nerve root compression with associated bone spur formation. After failing conservative management, the patient was taken to surgery for a three-level cervical disc replacement to decompress the spinal cord, relieve nerve compression, and remove osteophytic pathology.

"This case reflects the continued evolution of motion-preserving spine surgery," said Dr. Lanman. "The ability to address complex pathology while preserving motion is central to how we think about treating cervical degenerative disease."

Dr. Beckett added, "With the recent FDA approval of the Synergy Disc, we now have access to a technology designed not only to preserve motion but also to support segmental alignment. That combination is important as we continue to refine surgical decision-making in cervical spine care."

The Synergy Disc® is a motion-preserving artificial cervical disc developed by Synergy Spine Solutions and engineered with a lordotic polyethylene core designed to maintain and restore physiologic alignment while allowing controlled motion. The Synergy Disc® is the only artificial cervical disc currently available that combines motion preservation with intentional alignment correction in a single device. The device recently demonstrated superiority to anterior cervical discectomy and fusion (ACDF) in a U.S. Investigational Device Exemption (IDE) clinical trial.

The patient is recovering well following surgery with early reduction in pain. Neurologic recovery will be assessed over time as healing progresses.

This first U.S. case represents an early step in the clinical adoption of the Synergy Disc®, with broader utilization expected as surgeons gain experience with the newly approved technology.

About Dr. Todd Lanman

Todd Lanman, MD has over three decades of experience as a spinal neurosurgeon and has spent the last 25 years practicing spine surgery in Beverly Hills. In addition to being a world-renowned spinal surgeon, Dr. Lanman has also had 11 spinal surgeries including spinal fusions and artificial disc replacements. Because of these experiences as surgeon and as patient, Dr. Lanman brings a unique perspective to his surgical practice.

About Dr. Joel S. Beckett

Joel S. Beckett, MD is a board-certified, dual fellowship-trained neurosurgeon specializing in complex spinal reconstruction, artificial disc replacement, and motion-preserving spine surgery. Educated at Yale, trained at UCLA, and refined at the Cleveland Clinic, Dr. Beckett combines rigorous academic training with advanced surgical technique. He is a former Director of Neurosurgical Spinal Oncology at UCLA and has authored more than 50 scientific publications, including work in AI-enhanced imaging and surgical planning.

About Lanman Spinal Neurosurgery

Lanman Spinal Neurosurgery is committed to improving patients' quality of life by relieving pain and restoring spinal motion. The Beverly Hills practice has been at the leading edge of spine health for the past quarter of a century. Lanman Spinal Neurosurgery has and continues to pioneer artificial disc replacement and fusion revision surgeries to help neck and back pain sufferers live their best lives.

About Beckett NeuroSpine

Beckett NeuroSpine is a specialty spine practice dedicated to the comprehensive treatment of spine disorders including complex and reconstructive spinal conditions. Led by dual fellowship-trained neurosurgeon Joel S. Beckett, MD, the practice emphasizes motion-preserving and minimally invasive techniques whenever appropriate while providing full spectrum spine care. Beckett NeuroSpine integrates advanced surgical planning, modern imaging technologies, and a patient-centered approach to deliver individualized treatment and restore function for patients with both routine and complex spinal pathology.

About Synergy Spine Solutions

The vision of Synergy Spine Solutions is to identify and commercialize innovative spine technologies that help surgeons improve their patients' quality of life and advance the standard of care. The company's flagship product, the Synergy Disc®, is the only device designed to restore both motion and alignment to the spine. For more information, visit www.synergyspinesolutions.com.

MEDIA CONTACT:
Brandi Kamenar
Brandi Kamenar Brand Management
BrandiKamenar.com
[email protected]
(310) 734-6180

SOURCE: Lanman Spinal Neurosurgery



View the original press release on ACCESS Newswire

J.P.Estrada--TFWP